TANG CAPITAL MANAGEMENT LLC Diversified Active

CIK: 0001232621 · Show all filings

Period: Q3 2013 (← Previous) (Next →)

Filing Date: Nov 14, 2013

Total Value ($000): $201,930 (37.0% shares, 63.0% debt)

Holdings (16)

— PDL BIOPHARMA INC 18.6%

Value ($000) $37,556 Shares 25,974,000 Est. Cost $1.41 Unrealized —

— OPKO HEALTH INC 15.3%

Value ($000) $30,939 Shares 25,000,000 Est. Cost $1.04 Unrealized —

— SALIX PHARMACEUTICALS INC 9.9%

Value ($000) $20,064 Shares 300,000 Est. Cost $66.15 Unrealized —

— MIRATI THERAPEUTICS INC 8.9%

Value ($000) $17,898 Shares 1,181,400 Est. Cost $15.15 Unrealized —

— MANNKIND CORP 8.5%

Value ($000) $17,110 Shares 17,144,000 Est. Cost $0.99 Unrealized —

— DENDREON CORP 8.0%

Value ($000) $16,191 Shares 26,515,000 Est. Cost $0.72 Unrealized —

— INTERMUNE INC 7.6%

Value ($000) $15,263 Shares 17,000,000 Est. Cost $0.83 Unrealized —

BMRN BIOMARIN PHARMACEUTICAL INC 6.5%

Value ($000) $13,157 Shares 182,300 Est. Cost $62.32 Unrealized +6.6%

— ONCOGENEX PHARMACEUTICALS INC 4.3%

Value ($000) $8,650 Shares 933,100 Est. Cost $9.80 Unrealized —

— SAVIENT PHARMACEUTICALS INC 3.6%

Value ($000) $7,314 Shares 30,476,000 Est. Cost $0.15 Unrealized —

— DEPOMED INC 3.1%

Value ($000) $6,244 Shares 835,931 Est. Cost $5.62 Unrealized —

— ENDOCYTE INC 3.1%

Value ($000) $6,209 Shares 465,763 Est. Cost $13.13 Unrealized —

— CORSICANTO LTD 1.4%

Value ($000) $2,762 Shares 2,500,000 Est. Cost $1.09 Unrealized —

— SOPHIRIS BIO INC 1.2%

Value ($000) $2,340 Shares 500,000 Est. Cost $4.68 Unrealized —

— DENDREON CORP 0.1%

Value ($000) $233 Shares 79,600 Est. Cost $4.12 Unrealized —

— AMBIT BIOSCIENCES CORP 0.0%

Value ($000) $0 Shares 46 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	PDL BIOPHARMA INC	25,974,000	$37,556	18.6%	$1.41	—	NOTE 2.875% 2/15/15	69329YAE4
—	OPKO HEALTH INC	25,000,000	$30,939	15.3%	$1.04	—	NOTE 3.0% 2/1/33	68375NAA1
—	SALIX PHARMACEUTICALS INC	300,000	$20,064	9.9%	$66.15	—	COM	795435106
—	MIRATI THERAPEUTICS INC	1,181,400	$17,898	8.9%	$15.15	—	COM	60468T105
—	MANNKIND CORP	17,144,000	$17,110	8.5%	$0.99	—	NOTE 3.750% 12/15/13	56400PAA0
—	DENDREON CORP	26,515,000	$16,191	8.0%	$0.72	—	NOTE 2.875% 1/15/16	24823QAC1
—	INTERMUNE INC	17,000,000	$15,263	7.6%	$0.83	—	NOTE 2.50% 9/15/18	45884XAE3
BMRN	BIOMARIN PHARMACEUTICAL INC	182,300	$13,157	6.5%	$62.32	+6.6%	COM	09061G101
—	ONCOGENEX PHARMACEUTICALS INC	933,100	$8,650	4.3%	$9.80	—	COM	68230A106
—	SAVIENT PHARMACEUTICALS INC	30,476,000	$7,314	3.6%	$0.15	—	NOTE 4.750% 2/1/18	80517QAA8
—	DEPOMED INC	835,931	$6,244	3.1%	$5.62	—	COM	249908104
—	ENDOCYTE INC	465,763	$6,209	3.1%	$13.13	—	COM	29269A102
—	CORSICANTO LTD	2,500,000	$2,762	1.4%	$1.09	—	NOTE 3.50% 1/15/32	220480AC1
—	SOPHIRIS BIO INC	500,000	$2,340	1.2%	$4.68	—	COM	83578Q209
—	DENDREON CORP	79,600	$233	0.1%	$4.12	—	COM	24823Q107
—	AMBIT BIOSCIENCES CORP	46	$0	0.0%	—	—	COM	02318X100